Brief: IGEA Pharma Expects Significant Impact On Net Sales In Second Half Of 2020

IGEA Pharma NV

31/05/2020 22:02

May 31 (Reuters) - IGEA Pharma NV  IGPH.S :
    * DUE TO ONGOING MARKET LAUNCH OF ITS PRODUCTS, LASTING MORE
THAN
EXPECTED, REVENUES CONTINUED TO BE MARGINAL FOR 2019
    * GROUP EXPECTS A SIGNIFICANT IMPACT ON NET SALES IN SECOND
HALF
OF 2020
    * 2019 LOSS PER SHARE OF USD 0.076
    * IGEA PHARMA- INTENDS TO STRENGTHEN E-COMMERCE-BASED
DISTRIBUTION
AND TO FURTHER DIVERSIFY ITS PRODUCT PORTFOLIO BY WAY OF RAISING
ADDITIONAL FUNDS
    * GROUP ANTICIPATED A POSTPONEMENT OF ITS SECOND ORDINARY
GENERAL
MEETING TO NEWLY 3 JULY 2020 

Source text for Eikon:  ID:nEQ57vNb8a 
Further company coverage:  IGPH.S 

 ((Reuters.Briefs@thomsonreuters.com;))